The controversial Lawrence H. Summers, former Harvard president: “we are not alone in seeing the enormous impact biomedical research in general, and stem cell science in particular, will have on the region and the nation. And the stakes here are very high. So make no mistake, there will be brutal competition. And there is much in which to take satisfaction. ...we not confuse a moment of leadership with enduring competitive strength.”
Joseph Fuller, CEO of the Monitor Action Group: If the United States and Boston (what about California?), are going to remain dominant in stem cell research in the face of competition from China, Singapore, Spain, the United Kingdom, and other countries, private individuals, venture capital – which is scarce in stem cell science – and state governments are going to have to fill the funding gap until the federal government begins to fund the research.
William A. Sahlman, Harvard Business School Professor: “young scientists are not going to embark on careers where they’re not sure of getting funding – or of getting tenure. If the best and brightest of the next generation of scientists turn away from stem cell research, we could be describing a disaster of unparalleled proportion.” Link